Nimesulide

Revision as of 19:47, 9 January 2015 by Rabin Bista (talk | contribs)
Jump to navigation Jump to search

Sandbox drug2

Sandbox drug2®

Black Box Warning

Adult Indications and Dosage

Pediatric Indications and Dosage

Contraindications

Warnings

Adverse Reactions

Drug Interactions

Use in Specific Populations

Administration and Monitoring

IV Compatibility

Overdosage

Pharmacology

Clinical Studies

How Supplied

Images

Patient Counseling Information

Precautions with Alcohol

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

For patient information regarding , click [[{{{genericName}}} (patient information)|here]].

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

ConditionName:

See full prescribing information for complete boxed warning.

ConditionName:

Content

Overview

Sandbox drug2 is a {{{drugClass}}} that is FDA approved for the treatment of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)Condition1 Dosing Information

Dosage

Condition2 Dosing Information

Dosage

Condition3 Dosing Information

Dosage

Condition4 Dosing Information

Dosage

Off-Label Use and Dosage (Adult)Guideline-Supported UseCondition1 Developed by:

Class of Recommendation:

Strength of Evidence:

Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Sandbox drug2 in adult patients.

Non–Guideline-Supported Use

Condition1 Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Sandbox drug2 in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)Condition1 Dosing Information

Dosage

Condition2

There is limited information regarding FDA-Labeled Use of Sandbox drug2 in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported UseCondition1 Developed by:

Class of Recommendation:

Strength of Evidence:

Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Sandbox drug2 in pediatric patients.

Non–Guideline-Supported Use

Condition1 Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Sandbox drug2 in pediatric patients.

Contraindications

Condition1

Warnings

ConditionName:

See full prescribing information for complete boxed warning.

ConditionName:

Content

Description

Precautions Description

Adverse ReactionsClinical Trials Experience

There is limited information regarding Clinical Trial Experience of Sandbox drug2 in the drug label.

Body as a Whole

CardiovascularDigestiveEndocrineHematologic and LymphaticMetabolic and NutritionalMusculoskeletalNeurologicRespiratorySkin and Hypersensitivy ReactionsSpecial SensesUrogenitalMiscellaneousPostmarketing Experience

There is limited information regarding Postmarketing Experience of Sandbox drug2 in the drug label.

Body as a Whole

CardiovascularDigestiveEndocrineHematologic and LymphaticMetabolic and NutritionalMusculoskeletalNeurologicRespiratorySkin and Hypersensitivy ReactionsSpecial SensesUrogenitalMiscellaneousDrug Interactions Drug

Description

Use in Specific PopulationsPregnancy

Pregnancy Category (FDA):

Pregnancy Category

Pregnancy Category (AUS):

Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Sandbox drug2 in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Sandbox drug2 during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Sandbox drug2 with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Sandbox drug2 with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Sandbox drug2 with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Sandbox drug2 with respect to specific gender populations.

Race

There is no FDA guidance on the use of Sandbox drug2 with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Sandbox drug2 in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Sandbox drug2 in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Sandbox drug2 in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Sandbox drug2 in patients who are immunocompromised.

Administration and Monitoring

Administration Oral

Intravenous

Monitoring

There is limited information regarding Monitoring of Sandbox drug2 in the drug label.

Description

IV Compatibility

There is limited information regarding IV Compatibility of Sandbox drug2 in the drug label.

Overdosage

Acute OverdoseSigns and Symptoms Description

Management Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Sandbox drug2 in the drug label.

Pharmacology

Mechanism of Action

Structure

File:Sandbox drug201.png

This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Sandbox drug2 in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Sandbox drug2 in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Sandbox drug2 in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Sandbox drug2 in the drug label.

How Supplied

Images

Drug Images

Drug Name: Ingredient(s): Imprint: Dosage: {{{dosageValue}}} {{{dosageUnit}}} Color(s): Shape: Size (mm): Score: NDC:

Drug Label Author:

This pill image is provided by the National Library of Medicine's PillBox.

Package and Label Display Panel

File:Sandbox drug211.png

This image of the FDA label is provided by the National Library of Medicine.

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Sandbox drug2 in the drug label.

Precautions with Alcohol

Alcohol-Sandbox drug2 interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names ®[1]

Look-Alike Drug Names A® — B®[2]

Drug Shortage StatusPrice

References

The contents of this FDA label are provided by the National Library of Medicine.

Jump up↑ You must specify title = and url = when using Empty citation (help)..